Jean‐Christophe Ouallet

ORCID: 0000-0003-3231-6416
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Systemic Sclerosis and Related Diseases
  • Systemic Lupus Erythematosus Research
  • Polyomavirus and related diseases
  • Health Systems, Economic Evaluations, Quality of Life
  • Viral Infections and Immunology Research
  • Hereditary Neurological Disorders
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Reproductive System and Pregnancy
  • RNA regulation and disease
  • Rheumatoid Arthritis Research and Therapies
  • Inflammasome and immune disorders
  • Full-Duplex Wireless Communications
  • Vestibular and auditory disorders
  • Advanced MRI Techniques and Applications
  • Neurogenesis and neuroplasticity mechanisms
  • Cerebrovascular and genetic disorders
  • Healthcare cost, quality, practices
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Sphingolipid Metabolism and Signaling
  • Mycobacterium research and diagnosis
  • Plant Virus Research Studies
  • Healthcare and Venom Research
  • Herpesvirus Infections and Treatments

Centre Hospitalier Universitaire de Bordeaux
2015-2024

Observatoire Français de la Sclérose en Plaques
2007-2024

St. Josef-Hospital
2024

University of Lausanne
2024

Centre Hospitalier Universitaire de Tours
2024

University Hospital of Lausanne
2021-2024

Hôpital Pellegrin
2009-2023

Université de Bordeaux
2004-2022

Inserm
1997-2021

Hôpital Gui de Chauliac
2021

Christine Lebrun‐Frénay Darin T. Okuda Aksel Sıva Cassandre Landes-Château Christina Azevedo and 95 more Lydiane Mondot Clarisse Carra‐Dallière Hélène Zéphir Céline Louapre Françoise Durand‐Dubief Emmanuelle Le Page Caroline Bensa Aurélie Ruet Jonathan Ciron David Laplaud Olivier Casez Guillaume Mathey de Sèze Burcu Zeydan Naila Makhani Melih Tütüncü Michaël Levraut Mikaël Cohen Éric Thouvenot Daniel Pelletier Orhun H. Kantarci Sabrina Sehaki Nathalie Devys-Meyer Matthieu Béreau Chrystelle Cappe Bruno Brochet Jean‐Christophe Ouallet Katy-Kim Kounkou Gilles Defer Pierre Branger Frédéric Taithe Émilie Dumont Edwige Lescieux Agnès Fromont Alexia Protin Maty Diop Kane Patrick Hautecœur Olivier Outteryck Patrick Vermersch Julie Boucher Julie Petit Irène Tabellah Kasonde Aymeric de Vilmarrest Laurent Magy Marie Nicol Muriel Malbezin Javier Olaiz Claire Rigaud-Bully Nadine Debard Sandra Vukusic François Cotton Iuliana Ionescu Amalle Abdelalli Jean Pelletier Bertrand Audoin Adil Maarouf Bernadette Di Lelio Xavier Ayrignac Pierre Labauge Frédéric Pinna Francis Guillemin Marc Debouverie Amandine Ziegler Sandrine Wiertlevski Saskia Bresch Céline Callier Elodie David Giovanni Castelnovo Caroline Papeix Élisabeth Maillart Catherine Lubetzki Karima Zehrouni Bertrand Fontaine C. Giannesini Jérôme Hodel Abir Wahab Mickaël Zedet Ombeline Fagniez Clémence Laage Corinne Pottier Iuliana Slesari Mathilde Sampaio Emilie Rabois Cédric Castex Benjamin Hébant Maxime Guillaume Christine Vimont Olivier Gout Antoine Guegen Laure Michel Romain Muraz Damien Le Port Emmanuelle Leray Carole Henry Thomas de Broucker Nicolas Collongues

The radiologically isolated syndrome (RIS) was defined in 2009 as the presence of asymptomatic, incidentally identified demyelinating-appearing white matter lesions CNS within individuals lacking symptoms typical multiple sclerosis (MS). RIS criteria have been validated and predict transition to symptomatic MS reliably. performance that require fewer MRI is unknown. 2009-RIS subjects, by definition, fulfil three four for 2005 dissemination space (DIS) subjects fulfilling only one or two at...

10.1093/brain/awad073 article EN Brain 2023-03-01

<h3>Background</h3> Exogenous sexual steroids together with pregnancy have been shown to influence the risk of relapses in multiple sclerosis (MS). Treatments used during assisted reproductive techniques may consequently short term evolution MS by modifying hormonal status patient. The objective this study was determine if there an increased developing exacerbations women after vitro fertilisation (IVF). <h3>Methods</h3> and IVF data were either automatically extracted from 13 French...

10.1136/jnnp-2012-302235 article EN Journal of Neurology Neurosurgery & Psychiatry 2012-06-11
Laëtitia Barbin Chloé Rousseau Natacha Jousset Romain Casey Marc Debouverie and 95 more Sandra Vukusic de Sèze David Brassat Sandrine Wiertlewski Bruno Brochet Jean Pelletier Patrick Vermersch Gilles Edan Christine Lebrun‐Frénay Pierre Clavelou Éric Thouvenot Jean‐Philippe Camdessanché Ayman Tourbah Bruno Stankoff Abdullatif Al Khedr Philippe Cabre Caroline Papeix Ėric Berger Olivier Heinzlef Thomas Debroucker Thibault Moreau Olivier Gout Bertrand Bourre Alain Créange Pierre Labauge Laurent Magy Gilles Defer Yohann Foucher David Laplaud O. Anne Bertrand Audouin Ėric Berger David Brassat Bruno Brochet Bertrand Bourre P. Cabré Jean‐Philippe Camdessanché O. Casez Pierre Clavelou Nicolas Collongues M. Coustans Alain Créange Marc Debouverie G. Defer Nathalie Derache de Sèze Dominique Dive Agnès Fromont R. Guider J Grimaud O. Heinzlef Arnaud Kiatkoswki Pierre Labauge David Laplaud Christine Lebrun‐Frénay Emmanuelle Le Page Romain Marignier T. Moreau Jean‐Christophe Ouallet Caroline Papeix Jean Pelletier Sophie Pittion L. Rumbach Myriam Schluep Pierrette Seeldrayers I. Slassi Sennou B. Stankoff Frederic Thaite Ayman Tourbah Éric Thouvenot Patrick Vermersch Sandra Vukusic Sandrine Wiertlewski Hélène Zéphir Sandra Vukusic Michel Clanet Bertrand Fontaine Bruno Stankoff Thibault Moreau Bruno Brochet Jean Pelletier de Sèze François Cotton Vincent Dousset David Laplaud de Sèze Sandra Vukusic Romain Marignier Françoise Durand‐Dubief Marc Debouverie Francis Guillemin S. Pittion‐Vouyovitch Gilles Edan Emmanuelle Leray Emmanuelle Le Page

To compare natalizumab and fingolimod on both clinical MRI outcomes in patients with relapsing-remitting multiple sclerosis (RRMS) from 27 centers participating the French follow-up cohort Observatoire of Multiple Sclerosis.Patients RRMS included study were aged 18 to 65 years an Expanded Disability Status Scale score 0-5.5 available brain performed within year before treatment initiation. The data collected for 326 treated 303 fingolimod. statistical analysis was using 2 different methods:...

10.1212/wnl.0000000000002395 article EN cc-by-nc-nd Neurology 2016-01-30

Inherited white matter diseases are rare and heterogeneous disorders usually encountered in infancy. Adult-onset forms increasingly recognized. Our objectives were to determine relative frequencies of genetic leukoencephalopathies a cohort adult-onset patients evaluate the effectiveness systematic diagnostic approach. Inclusion criteria this retrospective study were: (i) symmetrical involvement on first available brain MRI; (ii) age onset above 16 years. Patients with acquired excluded....

10.1093/brain/awu353 article EN Brain 2014-12-19
Christine Lebrun‐Frénay Fabien Rollot Lydiane Mondot Hélène Zéphir Céline Louapre and 95 more Emmanuelle Le Page Françoise Durand‐Dubief Pierre Labauge Caroline Bensa Éric Thouvenot David Laplaud de Sèze Jonathan Ciron Bertrand Bourre Philippe Cabre Olivier Casez Aurélie Ruet Guillaume Mathey Ėric Berger Thibault Moreau A. Al Khedr Nathalie Derache Pierre Clavelou Anne‐Marie Guennoc Alain Créange Jean‐Philippe Neau Ayman Tourbah Jean‐Philippe Camdessanché Adil Maarouf Céline Callier Patrick Vermersch Orhun H. Kantarci Aksel Sıva Christina Azevedo Naila Makhani Mikaël Cohen Daniel Pelletier Darin T. Okuda Sandra Vukusic Orhun H. Kantarci Aksel Sıva Daniel Pelletier Darin T. Okuda Christina Azevedo Naila Makhani Fataï Radji N. Costedoat‐Chalumeau Deborah Grosset-Jeannin Aurelian Ungureanu L Boyer Laurent Suchet Zyad Elias Christine Lebrun‐Frénay Mikaël Cohen Lydiane Mondot Éric Thouvenot Jonathan Ciron Françoise Durand‐Dubief Bruno Brochet Aurélie Ruet Jean‐Christophe Ouallet Gilles Defer Pierre Branger Nathalie Derache Pierre Clavelou Frédéric Taithe Adullatif Alkhedr Agnès Fromont Thibault Moreau Ayman Tourbah Olivier Casez Ėric Berger Hélène Zéphir Olivier Outteryck Patrick Vermersch Patrick Hautecœur G. Androdias Iuliana Ionescu Jean Pelletier Bertrand Audoin Adil Maarouf Xavier Ayrignac Clarisse Carra‐Dallière Pierre Labauge Marc Debouverie Guillaume Mathey Philippe Cabre David Laplaud Sandrine Wiertlevski Saskia Bresch Giovanni Castelnovo Caroline Papeix Céline Louapre Élisabeth Maillart Catherine Lubetzki Bruno Stankoff Bertrand Fontaine C. Giannesini Olivier Heinzleff Alain Créange

<h3>Importance</h3> Younger age, oligoclonal bands, and infratentorial spinal cord lesions are factors associated with an increased 10-year risk of clinical conversion from radiologically isolated syndrome (RIS) to multiple sclerosis (MS). Whether disease-modifying therapy is beneficial for individuals RIS currently unknown. <h3>Objectives</h3> To evaluate the 2-year a event (onset symptoms MS) prospectively, identify developing early event, simulate sample size needed phase III trial...

10.1001/jamanetworkopen.2021.28271 article EN cc-by-nc-nd JAMA Network Open 2021-10-11

Preliminary observations of humoral immunity against the myelin oligodendrocyte glycoprotein (MOG) in experimental allergic encephalomyelitis (EAE) and human multiple sclerosis (MS) suggest that a subset anti-MOG autoantibodies directed conformational epitopes is pathogenic predominance. Here, we provide proof marmoset EAE, reactive MOG are not only responsible for aggravating demyelination, but also an essential factor disease dissemination space within central nervous system, hallmark...

10.1002/eji.200425050 article EN European Journal of Immunology 2004-06-17

The multiple sclerosis functional composite (MSFC) includes the Paced Auditory Serial Addition test (PASAT) as a measure of cognition.We compared MSFC incorporating Symbol Digit Modalities (SDMT) (MSFC [sdmt]) to usually applied [pasat]) in sample 46 ptients with relapsing-remitting MS who were followed over five-year period. Magnetic resonance imaging was performed at baseline.The Expanded Disability Status scale (EDSS) deteriorated significantly 5 years (P < 0.01), but scores remained...

10.1177/1352458508094398 article EN Multiple Sclerosis Journal 2008-07-24

Background: Despite a growing use of rituximab (RTX) in neuromyelitis optica (NMO), data are lacking patients with refractory NMO (RNMO), defined as cases at least one relapse during immunosuppressive therapy. Objective: The purpose this study was to assess RTX maintenance therapy RNMO. Methods: Out total 305 from population-based cohort, 21 RNMO received mean follow-up period 31 months. Results: After RTX, 11 (52.3%) were free, meaning that 47.7% RTX. annualized rate decreased 1.3 0.4 (...

10.1177/1352458515602337 article EN Multiple Sclerosis Journal 2015-09-11

<h3>Background</h3> Cerebellar damage has been implicated in information processing speed (IPS) impairment associated with multiple sclerosis (MS) that might result from functional disconnection the frontocerebellar loop. Structural alterations individual posterior lobules, which cognitive functioning seems preponderant, are still unknown. Our aim was to investigate impact of grey matter (GM) volume lobules VI VIIIb on IPS persons clinically isolated syndrome (PwCIS), MS (PwMS) and healthy...

10.1136/jnnp-2016-313867 article EN Journal of Neurology Neurosurgery & Psychiatry 2016-10-27
Antoine Gavoille Fabien Rollot Romain Casey Anne Kerbrat Emmanuelle Le Page and 95 more Kévin Bigaut Guillaume Mathey Laure Michel Jonathan Ciron Aurélie Ruet Élisabeth Maillart Pierre Labauge Hélène Zéphir Caroline Papeix Gilles Defer Christine Lebrun‐Frénay Thibault Moreau Ėric Berger Bruno Stankoff Pierre Clavelou Eric Thouvenot Olivier Heinzlef Jean Pelletier Abdullatif Al-Khedr Olivier Casez Bertrand Bourre Philippe Cabre Abir Wahab Laurent Magy Jean‐Philippe Camdessanché Inès Doghri Solène Moulin Haifa Ben-Nasr Céline Labeyrie Karolina Hankiewicz Jean-Philippe Neau Corinne Pottier Chantal Nifle Éric Manchon Bertrand Lapergue Sandrine Wiertlewski de Sèze Sandra Vukusic David Laplaud François Cotton Pascal Douek Francis Guillemin Alexandre Pachot Javier Olaiz Claire Rigaud-Bully Romain Marignier Guillaume Mathey Anne Kerbrat Damien Biotti Jean‐Christophe Ouallet Nicolas Collongues Olivier Outteryck Xavier Moisset Nathalie Derache Mikaël Cohen Agnès Fromont Sandrine Wiertlewsky Matthieu Béreau Bertrand Audoin C. Giannesini Caroline Bensa Giovanni Castelnovo Ombeline Fagniez Benjamin Hébant Mathieu Vaillant Séverine Jeanin Alain Créange Jean-Michel Vallat Philippe Convers Stéphane Beltran Céline Labeyrie Carole Henry Marie Camuzeaux Maryline Delattre Laura Trotta Catherine Girod Amandine Ostermann-Ziegler Damien Le Port Noellie Freitas Carole Berthe Katy-Kim Lataste Karima Zehrouni Frédéric Pinna Julie Petit Sadou Safa Diallo Karine Droulon Céline Callier Alexia Protin Mélinda Moyon Chrystelle Cappe Émilie Dumont Hanane Agherbi Marie Blanchère Marie-Pierre Ranjeva Amandine Da Veiga

Understanding the association between clinically defined relapses and radiological activity in multiple sclerosis (MS) is essential for patient treatment therapeutic development. To investigate clinical events identified as but not associated with new T2 lesions or gadolinium-enhanced T1 on brain spinal cord magnetic resonance imaging (MRI). This multicenter observational cohort study was conducted January 2015 June 2023. Data were extracted 8, 2023, from French MS registry. All reported...

10.1001/jamaneurol.2024.1961 article EN JAMA Neurology 2024-07-01

Pain is a frequent symptom during the course of multiple sclerosis (MS) but its frequency and impact at early clinical stages remain unknown.The aim this study was to establish prevalence severity pain in cohort patients recently diagnosed with MS determine evolution over 2 years. Other objectives were investigate presence baseline predictors after years on quality life (QOL).In population-based sample 69 (<6 mo), measured using questions from SEP-59 QOL questionnaire. A standardized bedside...

10.1097/ajp.0b013e3181891347 article EN Clinical Journal of Pain 2009-02-13

In this study, we compared the effectiveness of teriflunomide (TRF) and dimethyl fumarate (DMF) on both clinical MRI outcomes in patients followed prospectively Observatoire Français de la Sclérose en Plaques.A total 1,770 with relapsing-remitting multiple sclerosis (RRMS) (713 TRF 1,057 DMF) an available baseline brain were included intention to treat. The 1- 2-year postinitiation relapses, increase T2 lesions, Expanded Disability Status Scale score, reason for treatment discontinuation....

10.1212/wnl.0000000000007938 article EN cc-by-nc-nd Neurology 2019-07-13

Background: Patients with multiple sclerosis who have poor adherence to treatment a higher risk of relapse than adherent patients. This study assessed to, and effectiveness convenience of, subcutaneous (sc) interferon (IFN) β-1a (Rebif®, Merck Serono SA) 44 or 22 μg three times weekly in patients relapsing (RMS) using the RebiSmart® electronic, multidose, autoinjector for 1 year.Study design: European, multicentre, observational among neurologists: inclusion criteria included RMS, Expanded...

10.1517/17425247.2015.1057567 article EN Expert Opinion on Drug Delivery 2015-06-22

Background and purpose BIONAT is a F rench multicentric phase IV study of natalizumab ( NTZ )‐treated relapsing−remitting multiple sclerosis (MS) patients. The this was to collect clinical, radiological biological data on 1204 patients starting , evaluate the clinical/radiological response after 2 years treatment. Methods Patients at 18 MS centres since J une 2007 were included. Good defined by absence clinical activity. Data analysed in first report focus who started least ago n = 793; 2Y...

10.1111/ene.12204 article EN European Journal of Neurology 2013-06-12

Objectives: To identify predictors of conversion to definite multiple sclerosis (MS) in patients with a cord clinically isolated syndrome. Methods: The predictive values for MS clinical, magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) variables 114 acute partial myelitis confirmed by spinal lesion on MRI were studied. Other causes syndromes excluded. Results: was diagnosed 78 (86%) during 4.0 ± 1.9 years follow-up. Some 67 these had second clinical episode. diagnosis...

10.1177/1352458510386999 article EN Multiple Sclerosis Journal 2010-11-11

<h3>BACKGROUND AND PURPOSE:</h3> In multiple sclerosis, gadolinium enhancement is used to classify lesions as active. Regarding the need for a standardized and accurate method detection of sclerosis activity, we compared 2D-spin-echo with 3D-gradient-echo T1WI gadolinium-enhancing MS lesions. <h3>MATERIALS METHODS:</h3> Fifty-eight patients were prospectively imaged at 3T by using both 3D-gradient recalled-echo in random order after injection gadolinium. Blinded independent evaluation was...

10.3174/ajnr.a4152 article EN cc-by American Journal of Neuroradiology 2014-11-06

Background Therapeutic options are limited in secondary progressive multiple sclerosis (SPMS). Open-label studies suggested efficacy of monthly IV cyclophosphamide (CPM) without induction for delaying progression but no randomized trial was conducted so far. Objective To compare CPM to methylprednisolone (MP) SPMS. Methods Randomized, double-blind clinical on two parallel groups. Patient with SPMS, a documented worsening the Expanded Disability Status Scale (EDSS) score during last year and...

10.1371/journal.pone.0168834 article EN cc-by PLoS ONE 2017-01-03

To determine whether adult cases of Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS) may be related familial hemophagocytic lymphohistiocytosis (HLH) causes, we have screened patients adult-onset CLIPPERS for mutations in primary HLH-associated genes.In our cohort 36 fulfilling the criteria probable or definite according CLIPPERS-2017 criteria, conducted a first study on 12 who consented genetic testing. In these patients, systemic HLH...

10.1212/nxi.0000000000000970 article EN cc-by-nc-nd Neurology Neuroimmunology & Neuroinflammation 2021-03-03
Béatrice Pignolet Nicholas Schwab Tilman Schneider‐Hohendorf Florence Bucciarelli Damien Biotti and 95 more Delphine Averseng-Peaureaux Olivier Outteryck Jean-Claude Ongagna de Sèze Bruno Brochet Jean‐Christophe Ouallet Marc Debouverie Sophie Pittion Gilles Defer Nathalie Derache Patrick Hautecœur Ayman Tourbah Pierre Labauge Giovanni Castelnovo Pierre Clavelou Ėric Berger Jean Pelletier Audrey Rico Hélène Zéphir David Laplaud Sandrine Wiertlewski William Camu Éric Thouvenot Olivier Casez Thibault Moreau Agnès Fromont Sandra Vukusic Caroline Papeix Patrick Vermersch Manuel Comabella Christine Lebrun‐Frénay Heinz Wiendl David Brassat David Brassat Béatrice Pignolet Florence Bucciarelli Nicholas Schwab Tilman Schneider‐Hohendorf Heinz Wiendel Manuel Comabella Nicolás Fissolo María Martínez Alexia di-Paolo Florence Umuhoza Lise Scandella Sarah Exbrayat David Brassat Olivier Outteryck Jean-Claude Ongagna de Sèze Bruno Brochet Jean‐Christophe Ouallet Marc Debouverie Sophie Pittion Gilles Defer Nathalie Derache Patrick Hautecœur Ayman Tourbah Prof Pierre Labauge Giovanni Castelnovo Pierre Clavelou Ėric Berger Jean Pelletier Audrey Rico Hélène Zéphir David Laplaud Sandrine Wiertlewski Philippe Cabre William Camu Éric Thouvenot Olivier Casez MD . Thibault Moreau Agnès Fromont Sandra Vukusic Caroline Papeix Catherine Lubetzki Patrick Vermersch Christine Lebrun‐Frénay Mikaël Cohen MD Lucien Rumbach Olivier Heinzlef Prof Jérôme de Sèze Sophie Pittion Hélène Zéphir Olivier Anne Bertrand Audoin Caroline Bensa Ėric Berger David Brassat Prof Bruno Brochet Bertrand Bourre Philippe Cabre Jean‐Philippe Camdessanché Olivier Casez Giovanni Castelnovo

Flashes of light or phosphenes are the sensation without actually entering eye. This phenomenon can be evoked by stimulation retina visual cortex brain and appear unilaterally bilaterally. From an ophthalmologic perspective, arise from photoreceptor induction mechanical,1,2 inflammatory,3 vascular4 stimuli. Therefore, it is necessary to determine origin for further management. We encountered a patient who reported having while moving his eyes laterally. performed various imaging studies...

10.1212/wnl.0000000000003401 article EN Neurology 2016-11-05
Coming Soon ...